NASDAQ · Analyst Forecast

TELA Bio, Inc. (TELA) Stock Forecast & Price Target

$0.76 NASDAQ: TELA Market Cap $34.44M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering TELA Bio, Inc. (TELA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For TELA Bio, Inc., analysts forecast revenue rising from $57.95M in 2023 to $92.33M in 2028; the average estimate for 2028 earnings per share is −$0.35; with published estimates ranging from −$0.36 to −$0.34; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$0.76
Consensus targetThe average of the price targets analysts have published.$2.00
Median targetThe middle target, less affected by a single outlier.$2.00
Highest targetThe most optimistic published target.$2.00
Lowest targetThe most pessimistic published target.$2.00
Difference from priceHow far the consensus target sits from today’s price.+163.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2023$57.70M$57.95M$58.20M3
2024$74.22M$74.71M$75.21M3
2025$79.05M$80.44M$82.16M3
2026$75.19M$76.51M$78.15M2
2027$80.36M$81.77M$83.52M3
2028$86.78M$92.33M$97.77M4

Earnings per share forecast

YearLowAverageHighAnalysts
2023−$1.96−$1.93−$1.913
2024−$1.45−$1.37−$1.293
2025−$0.84−$0.82−$0.803
2026−$0.67−$0.66−$0.642
2027−$0.49−$0.48−$0.473
2028−$0.36−$0.35−$0.344

TELA Bio, Inc. (TELA) forecast — frequently asked questions

What is the analyst price target for TELA Bio, Inc.?

Analysts covering TELA Bio, Inc. (TELA) have a consensus price target of $2.00, 163.2% above the current price of $0.76. Published targets range from $2.00 to $2.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for TELA Bio, Inc.'s earnings?

The average analyst estimate for TELA Bio, Inc. (TELA) earnings per share in 2028 is -0.35, with individual estimates between -0.36 and -0.34.

How much revenue is TELA Bio, Inc. expected to make?

Analysts forecast TELA Bio, Inc. (TELA) revenue of $92.33M in 2028, based on 4 published estimates.

How many analysts cover TELA?

4 analysts contribute estimates for TELA Bio, Inc. (TELA). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.